A detailed history of Harbour Investments, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 149 shares of TGTX stock, worth $5,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares
149
Previous 149 -0.0%
Holding current value
$5,104
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$13.32 - $19.19 $1,984 - $2,859
149 New
149 $2,000
Q4 2021

Feb 16, 2022

SELL
$15.2 - $35.51 $425 - $994
-28 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$21.78 - $40.45 $23,282 - $43,241
-1,069 Reduced 97.45%
28 $1,000
Q2 2021

Aug 16, 2021

BUY
$32.5 - $48.96 $34,775 - $52,387
1,070 Added 3962.96%
1,097 $43,000
Q1 2021

Aug 17, 2021

BUY
$41.61 - $54.3 $1,123 - $1,466
27 New
27 $1,000
Q1 2021

May 12, 2021

BUY
$41.61 - $54.3 $0 - $0
0 New
0 $0

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.98B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.